IL149243A0 - Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same - Google Patents

Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same

Info

Publication number
IL149243A0
IL149243A0 IL14924300A IL14924300A IL149243A0 IL 149243 A0 IL149243 A0 IL 149243A0 IL 14924300 A IL14924300 A IL 14924300A IL 14924300 A IL14924300 A IL 14924300A IL 149243 A0 IL149243 A0 IL 149243A0
Authority
IL
Israel
Prior art keywords
salts
tetrapeptide
proposed
neurones
glu
Prior art date
Application number
IL14924300A
Other languages
English (en)
Original Assignee
Sankt Peterburgskaya Obschestv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankt Peterburgskaya Obschestv filed Critical Sankt Peterburgskaya Obschestv
Publication of IL149243A0 publication Critical patent/IL149243A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14924300A 1999-10-20 2000-05-25 Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same IL149243A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU99121778/14A RU2155063C1 (ru) 1999-10-20 1999-10-20 Тетрапептид, стимулирующий функциональную активность нейронов, фармакологическое средство на его основе и способ его применения
PCT/RU2000/000218 WO2001029067A1 (fr) 1999-10-20 2000-05-25 Tetrapeptide stimulant l'activite fonctionnelle des neurones, agent pharmacologique base sur ce tetrapeptide et procede d'utilisation correspondant

Publications (1)

Publication Number Publication Date
IL149243A0 true IL149243A0 (en) 2002-11-10

Family

ID=20225904

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14924300A IL149243A0 (en) 1999-10-20 2000-05-25 Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same

Country Status (10)

Country Link
US (1) US7189701B1 (fr)
EP (1) EP1224212B1 (fr)
JP (1) JP4668497B2 (fr)
AT (1) ATE244727T1 (fr)
AU (1) AU784578B2 (fr)
CA (1) CA2388357A1 (fr)
DE (1) DE60003837T2 (fr)
IL (1) IL149243A0 (fr)
RU (1) RU2155063C1 (fr)
WO (1) WO2001029067A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
EP1138692A1 (fr) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments de gonadotrophine chorionique humaine comme immunorégulateurs
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6921751B1 (en) 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US7175679B2 (en) 2001-03-29 2007-02-13 Biotempt B.V. Oligopeptide treatment of NF-κB mediated inflammation
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US7576174B2 (en) 2000-03-29 2009-08-18 Biotempt B.V. Compositions capable of reducing elevated blood urea concentration
EP1300418A1 (fr) 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Régulation génétique par des oligopeptides
RU2161501C1 (ru) * 2000-06-29 2001-01-10 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Способ получения пептидов, обладающих тканеспецифической активностью, и фармацевтические композиции на их основе
US7501391B2 (en) 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
RU2244928C2 (ru) * 2003-02-19 2005-01-20 Пинигина Нина Максимовна Эндогенная фармацевтическая композиция, полученная на основе целенаправленной активации гуморальных медиаторов нервных окончаний коры головного мозга
JP4846799B2 (ja) 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
EP1864692A1 (fr) 2006-06-07 2007-12-12 Biotempt B.V. Utilisation de peptides pour la protection contre les radiolésions
EP1857463A1 (fr) 2006-05-03 2007-11-21 Ebewe Pharma Ges.m.b.H. Nfg. KG Peptide à effets neuroprotecteurs
RU2301678C1 (ru) * 2006-05-30 2007-06-27 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, стимулирующий регенерацию нейронов центральной нервной системы, фармацевтическая композиция на его основе и способ ее применения
EP2000134A1 (fr) * 2007-06-06 2008-12-10 Neuraxo Biopharmaceuticals GmbH Utilisation d'une substance pour l'amélioration des lésions pns
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
EA020866B1 (ru) 2013-02-28 2015-02-27 Замертон Холдингс Лимитед Пептиды с цитопротекторной активностью и фармацевтическая композиция
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
EP3914280B1 (fr) * 2019-01-25 2024-03-27 The Board of Regents of The University of Texas System Nouveau médicament anti-douleur non opioïde
RU2768475C1 (ru) * 2021-07-08 2022-03-24 Общество с ограниченной ответственностью "ТЕРРАНОВА КАПИТАЛ" Пептид, обладающий нейростимулирующей активностью и восстанавливающий способность к обучению и формированию памяти, фармацевтическая композиция на его основе и способ ее применения

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652334A (en) * 1993-09-08 1997-07-29 City Of Hope Method for design of substances that enhance memory and improve the quality of life

Also Published As

Publication number Publication date
JP4668497B2 (ja) 2011-04-13
ATE244727T1 (de) 2003-07-15
EP1224212B1 (fr) 2003-07-09
DE60003837T2 (de) 2004-06-03
US7189701B1 (en) 2007-03-13
JP2003532630A (ja) 2003-11-05
WO2001029067A1 (fr) 2001-04-26
RU2155063C1 (ru) 2000-08-27
EP1224212A1 (fr) 2002-07-24
CA2388357A1 (fr) 2001-04-26
AU5258500A (en) 2001-04-30
AU784578B2 (en) 2006-05-04
DE60003837D1 (de) 2003-08-14

Similar Documents

Publication Publication Date Title
IL149243A0 (en) Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same
IL146432A0 (en) A tetrapeptide and a pharmaceutical composition containing the same
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
HUP0203870A2 (hu) Adenozinreceptor agonistát vagy antagonistát tartalmazó gyógyászati készítmény
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
MY128014A (en) Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors
TR200101633T2 (tr) Farmasötik bileşim
IL194500A0 (en) Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application
PT1027053E (pt) Metodo de prevencao de nefrotoxicidade provocada por ciclosporinas e tacrolimus
ATE513845T1 (de) Peptidsubstanz mit immunogeroprotektiver wirkung, darauf basierende pharmazeutische zusammensetzung und verfahren zu ihrer anwendung
SE9901572D0 (sv) New compounds
CA2425445A1 (fr) Substance tetrapeptidique stimulant l'activite fonctionnelle des hepatocytes, substance pharmacologique obtenue sur cette base et procede d'application
CA2382654A1 (fr) Nouveaux derives a-500359
AU3231901A (en) Phenoxyalkylamine derivatives useful as opioid delta receptor agonists
MY122570A (en) Benzamide derivatives and drugs containing the same
ES2010435A6 (es) Metodo para preparar preventivos y remedios para el envenenamiento medicinal y alcoholico.
CA2547873A1 (fr) Tetrapetpide regulant le taux de sucre sanguin dans le cadre du diabete sucre
CA2499620A1 (fr) Preparation externe contenant de l'acide acetylsalicylique pour inhiber la formation de cicatrices cheloidiennes
IL143873A0 (en) Dry skin remedies
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
EA200601581A1 (ru) Пептид, стимулирующий регенерацию ткани печени, фармацевтическая композиция на его основе и способ ее применения
RU99112967A (ru) Способ лечения и профилактики дизентерии свиней